| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| 姜超尚Executive Director | 13.83K | -- | Derivatives acquired | 13.83K | 0.07% | ||
| 王一峰Executive Director | 11.07K | -- | Derivatives acquired | 11.07K | 0.06% | ||
| 盛云Executive Director | 19.37K | -- | Derivatives acquired | 19.37K | 0.10% | ||
| 王升杨Executive Director | 19.37K | -- | Derivatives acquired | 19.37K | 0.10% |
Changes in interests filed with HKEX by directors and chief executives. The bought/sold totals count long-position purchases and sales only; option exercises, grants and other events are left out.
| Shareholder | |||
|---|---|---|---|
| 王升杨Executive Director | 0.10% | 19.37K | |
| 盛云Executive Director | 0.10% | 19.37K | |
| 姜超尚Executive Director | 0.07% | 13.83K | |
| 王一峰Executive Director | 0.06% | 11.07K |
From the HKEXnews Disclosure of Interests complete list of directors: each director's long position after their latest filing.
This page shows share dealings filed by NOVOSENSE (02676) directors and chief executives over the past year (date, shares, price, type and holding afterwards) with bought and sold totals, and each director's current holding. Data comes from the HKEXnews Disclosure of Interests (DI) section.

